The life sciences industry has long been at the forefront of innovation, and 2025 promises to continue this trajectory with exciting developments in intellectual property (IP), licensing, and mergers and acquisitions (M&A)....more
1/20/2025
/ Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Data Protection ,
Innovation ,
Intellectual Property Protection ,
IP License ,
Life Sciences ,
Machine Learning ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Popular
With the consequences of the global pandemic still reverberating throughout the Asia-Pacific region, governments and businesses in the area continue to focus on the life sciences industry. From startups to global...more
Against the backdrop of a slower M&A market, collaborations between biotech companies and pharma companies have remained robust, particularly those focusing on innovation and collaboration for value creation. According to a...more